Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells
Marta Lustig, Chilam Chan, J.H. Marco Jansen, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18

Showing 18 citing articles:

Genetics of glycosylation in mammalian development and disease
Pamela Stanley
Nature Reviews Genetics (2024)
Closed Access | Times Cited: 12
Dissecting the Ability of Siglecs To Antagonize Fcγ Receptors
Kelli A. McCord, Chao Wang, Mirjam Anhalt, et al.
ACS Central Science (2024) Vol. 10, Iss. 2, pp. 315-330
Open Access | Times Cited: 11
Tumor-infiltrating myeloid cells; mechanisms, functional significance, and targeting in cancer therapy
Fatemeh Sadat Toghraie, Maryam Bayat, Mahsa Sadat Hosseini, et al.
Cellular Oncology (2025)
Open Access
Targeting myeloid cells for cancer immunotherapy: Siglec-7/9/10/15 and their ligands
Kelly Boelaars, Yvette van Kooyk
Trends in cancer (2023) Vol. 10, Iss. 3, pp. 230-241
Open Access | Times Cited: 16
Targeting immune checkpoints on myeloid cells: current status and future directions
Chuhan Ma, Yang Li, Mei-Ye Li, et al.
Cancer Immunology Immunotherapy (2025) Vol. 74, Iss. 2
Open Access
Regulation of sialic acid metabolism in cancer
Filip Filipsky, Heinz Läubli
Carbohydrate Research (2024) Vol. 539, pp. 109123-109123
Open Access | Times Cited: 4
Targeting Siglec–Sialylated MUC1 Immune Axis in Cancer
Ramya Ayyalasomayajula, Mare Čudić
Cancers (2024) Vol. 16, Iss. 7, pp. 1334-1334
Open Access | Times Cited: 3
Antibody-lectin chimeras for glyco-immune checkpoint blockade
Jessica C. Stark, Melissa A. Gray, Simon Wisnovsky, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 10
Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9
Chilam Chan, Marta Lustig, J.H. Marco Jansen, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3405-3405
Open Access | Times Cited: 5
Glycosylation in the tumor immune response: the bitter side of sweetness
Yuting Cao, Wen Yi, Qiang Zhu
Acta Biochimica et Biophysica Sinica (2024) Vol. 56, Iss. 8, pp. 1184-1198
Open Access | Times Cited: 1
Sialic acid and Siglec receptors in tumor immunity and immunotherapy
Natália Rodrigues Mantuano, Heinz Läubli
Seminars in Immunology (2024) Vol. 74-75, pp. 101893-101893
Open Access | Times Cited: 1
SIGLEC-5/14 Inhibits CD11b/CD18 Integrin Activation and Neutrophil-Mediated Tumor Cell Cytotoxicity
Panagiota Bouti, Colin Blans, Bart Klein, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17141-17141
Open Access | Times Cited: 2
Impact of the Siglec-Sialoglycan Axis on the Cancer Immune Response
Mohammed Saqif Ahmad, Sara Seriah, Shoib Sarwar Siddiqui
Interdisciplinary cancer research (2024)
Closed Access
Sour Consequences of Aberrant Glycosylation in Cancer Development
María Florencia Festari, Valeria da Costa, Ignacio Rodríguez, et al.
Interdisciplinary cancer research (2024)
Closed Access
Mechanistic and Therapeutic Implications of Protein and Lipid Sialylation in Human Diseases
Xiaotian Zhong, Aaron M. D’Antona, Jason C. Rouse
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 22, pp. 11962-11962
Open Access
Integrated multiomics analysis unveils how macrophages drive immune suppression in breast tumors and affect clinical outcomes
Youness Azimzade, Mads H. Haugen, Vessela N. Kristensen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Sialylation inhibition improves macrophage mediated tumor cell phagocytosis of breast cancer cells triggered by therapeutic antibodies of different isotypes
Marta Lustig, Christoph Hahn, Marie Leangen Herigstad, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
ST6GAL1-mediated sialyl linkage switching in tumor-associated macrophages drives cancer-promoting nanotubes carrying α2,6-sialylation in anti-inflammatory cells
Priya Dipta, Naaz Bansal, Zeynep Sumer‐Bayraktar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1

Scroll to top